Article

Blohmer, Jens-Uwe, Paepke, Stefan, Sehouli, Jalid, Boehmer, Dirk, Kolben, Martin, Würschmidt, Florian, Petry, Karl U, Kimmig, Rainer, Elling, Dirk, Thomssen, Christoph, von Minckwitz, Gunter, Möbus, Volker, Hinke, Axel, Kümmel, Sherko, Budach, Volker, Lichtenegger, Werner and Schmid, Peter (2011) Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study. Journal of Clinical Oncology, 29 (28). pp. 3791-3797. ISSN 1527-7755

Blohmer, J.U., Paepke, P., Sehouli, J., Boehmer, D., Kolben, M., Würschmidt, F., Petry, K.U., Kimmig, R., Elling, D., Thomssen, C., von Minckwitz, G., Möbus, V., Hinke, A., Kümmel, S., Budach, V., Lichtenegger, W. and Schmid, P. (2011) A randomized Phase III trial of Sequential Adjuvant Chemo-Radiotherapy with or without Epoetin Alfa in Patients with High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study. Journal of Clinical Oncology, 29 (28). pp. 3791-3797. ISSN 0732-183X

Berry, Donald A, Ueno, Naoto T, Johnson, Marcella M, Lei, Xiudong, Caputo, Jean, Smith, Dori A, Yancey, Linda J, Crump, Michael, Stadtmauer, Edward A, Biron, Pierre, Crown, John P, Schmid, Peter, Lotz, Jean-Pierre, Rosti, Giovanni, Bregni, Marco and Demirer, Taner (2011) High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials. Journal of Clinical Oncology, 29 (24). pp. 3224-3231. ISSN 1527-7755

Syed, Nelofer, Coley, Helen M, Sehouli, Jalid, Koensgen, Dominique, Mustea, Alexander, Szlosarek, Peter, McNeish, Iain, Blagden, Sarah P, Schmid, Peter, Lovell, David P, Hatzimichael, Eleftheria and Crook, Tim (2011) Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer. Cancer Research, 71 (9). pp. 3317-3327. ISSN 0008-5472

Correa, C, Schmid, P and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. Journal of the National Cancer Institute Monographs, 2010 (41). pp. 162-177. ISSN 1745-6614

Blackhall, Fiona H, O'brien, Mary, Schmid, Peter, Nicolson, Marianne, Taylor, Paul, Milenkova, Tsveta, Kennedy, Sarah J and Thatcher, Nick (2010) A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer. Journal of Thoracic Oncology, 5 (8). pp. 1285-1288. ISSN 1556-1380

Blohmer, J.U., Schmid, Peter, Hilfrich, J., Friese, K., Kleine-Tebbe, A., Koelbl, H., Sommer, H., Morack, G., Wischnewsky, M.B., Lichtenegger, W. and Kuemmel, S. (2010) Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial. Annals of Oncology, 21 (7). pp. 1430-1435. ISSN 0923-7534

Schmid, Peter, Kiewe, P., Possinger, K., Korfel, A., Lindemann, S., Giurescu, M., Reif, S., Wiesinger, H., Thiel, E. and Kuhnhardt, D. (2010) Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors. Annals of Oncology, 21 (3). pp. 633-639. ISSN 0923-7534

Schmid, Peter, Nagai, Yutaka, Agarwal, Roshan, Hancock, Barry, Savage, Philip M, Sebire, Neil J, Lindsay, Iain, Wells, Michael, Fisher, Rosemary A, Short, Delia, Newlands, Edward S, Wischnewsky, Manfred B and Seckl, Michael J (2009) Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. The Lancet, 374 (9683). pp. 48-55. ISSN 0140-6736

Schmid, Peter, Nagai, Yutaka, Agarwal, Roshan, Hancock, Barry, Savage, Philip M., Sebire, Neil J., Lindsay, Iain, Wells, Michael, Fisher, Rosemary A., Short, Delia, Newlands, Edward S., Wischnewsky, Manfred B. and Seckl, Michael J. (2009) Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet, 374 (9683). pp. 48-55. ISSN 0140-6736

Schmid, P, Kühnhardt, D, Kiewe, P, Lehenbauer-Dehm, S, Schippinger, W, Greil, R, Lange, W, Preiss, J, Niederle, N, Brossart, P, Freier, W, Kümmel, S, Van de Velde, H, Regierer, A and Possinger, K (2008) A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines. Annals of Oncology, 19 (5). pp. 871-876. ISSN 1569-8041

Schmid, Peter, Untch, Michael, Kossé, Valentin, Bondar, Grigorij, Vassiljev, Leonid, Tarutinov, Valerie, Lehmann, Ute, Maubach, Lutz, Meurer, Juergen, Wallwiener, Diethelm and Possinger, Kurt (2007) Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study. Journal of Clinical Oncology, 25 (18). pp. 2509-2515. ISSN 1527-7755

Schmid, P, Krocker, J, Jehn, C, Michniewicz, K, Lehenbauer-Dehm, S, Eggemann, H, Heilmann, V, Kümmel, S, Schulz, C O, Dieing, A, Wischnewsky, M B, Hauptmann, S, Elling, D, Possinger, K and Flath, B (2005) Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial. Annals of Oncology, 16 (10). pp. 1624-1631. ISSN 0923-7534